Cite
HARVARD Citation
Schreuer, M. et al. (2016). Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors. Journal of translational medicine. 14 (1), pp. 1-11. [Online].